159 related articles for article (PubMed ID: 20639044)
1. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.
Mesrobian HG; Mitchell ME; See WA; Halligan BD; Carlson BE; Greene AS; Wakim BT
J Urol; 2010 Aug; 184(2):709-14. PubMed ID: 20639044
[TBL] [Abstract][Full Text] [Related]
2. Urinary proteome analysis in patients with stable SFU grade 4 ureteropelvic junction obstruction differs from normal.
Mesrobian HG; Kryger JV; Groth TW; Fiscus GE; Mirza SP
Urology; 2013 Sep; 82(3):745.e1-10. PubMed ID: 23987180
[TBL] [Abstract][Full Text] [Related]
3. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.
Decramer S; Wittke S; Mischak H; Zürbig P; Walden M; Bouissou F; Bascands JL; Schanstra JP
Nat Med; 2006 Apr; 12(4):398-400. PubMed ID: 16550189
[TBL] [Abstract][Full Text] [Related]
4. Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling.
Bandin F; Siwy J; Breuil B; Mischak H; Bascands JL; Decramer S; Schanstra JP
J Urol; 2012 Mar; 187(3):1006-11. PubMed ID: 22264461
[TBL] [Abstract][Full Text] [Related]
5. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
Kajbafzadeh AM; Elmi A; Talab SS; Emami H; Esfahani SA; Saeedi P
J Urol; 2010 Jun; 183(6):2353-60. PubMed ID: 20400153
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
[TBL] [Abstract][Full Text] [Related]
7. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY
Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrent ureteropelvic junction obstruction after open pyeloplasty in a large pediatric cohort.
Braga LH; Lorenzo AJ; Bägli DJ; Keays M; Farhat WA; Khoury AE; Salle JL
J Urol; 2008 Oct; 180(4 Suppl):1684-7; discussion 1687-8. PubMed ID: 18708226
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction.
Sundaram CP; Grubb RL; Rehman J; Yan Y; Chen C; Landman J; McDougall EM; Clayman RV
J Urol; 2003 Jun; 169(6):2037-40. PubMed ID: 12771713
[TBL] [Abstract][Full Text] [Related]
10. Urinary sodium dodecyl sulfate electrophoresis with silver staining: a noninvasive diagnostic tool for obstructive uropathy in children.
Beckers G; Mann H; Melzer H; Bemelmans B; Jakse G; Rohrmann D
J Urol; 2008 Feb; 179(2):703-7. PubMed ID: 18082830
[TBL] [Abstract][Full Text] [Related]
11. Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis?
Song SH; Lee SB; Park YS; Kim KS
J Urol; 2007 Mar; 177(3):1098-101; discussion 1101. PubMed ID: 17296419
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine.
Taha MA; Shokeir AA; Osman HG; Abd el-Aziz Ael-A; Farahat SE
Urology; 2007 Mar; 69(3):560-4; discussion 564-5. PubMed ID: 17382166
[TBL] [Abstract][Full Text] [Related]
13. The kidney in congenital ureteropelvic junction obstruction: a spectrum from normal to nephrectomy.
Rosen S; Peters CA; Chevalier RL; Huang WY
J Urol; 2008 Apr; 179(4):1257-63. PubMed ID: 18280506
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction.
Chen H; Lin H; Xu M; Xu G; Fang X; He L; Chen Z; Wu Z; Geng H
Proteomics Clin Appl; 2019 Jul; 13(4):e1800101. PubMed ID: 30471240
[TBL] [Abstract][Full Text] [Related]
15. A novel method of evaluating ureteropelvic junction obstruction: dynamic near infrared fluorescence imaging compared to standard modalities to assess urinary obstruction in a swine model.
Rowe CK; Franco FB; Barbosa JA; Minnillo BJ; Chow JS; Treves T; Retik AB; Nguyen HT
J Urol; 2012 Nov; 188(5):1978-85. PubMed ID: 22999537
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic management of ureteropelvic junction obstruction in patients with upper urinary tract anomalies.
Bove P; Ong AM; Rha KH; Pinto P; Jarrett TW; Kavoussi LR
J Urol; 2004 Jan; 171(1):77-9. PubMed ID: 14665848
[TBL] [Abstract][Full Text] [Related]
17. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624
[TBL] [Abstract][Full Text] [Related]
18. Role of urinary tubular enzymes in evaluation of children with ureteropelvic junction narrowing under conservative management.
Shokeir AA; Taha MA
Urology; 2009 May; 73(5):1016-20. PubMed ID: 19394498
[TBL] [Abstract][Full Text] [Related]
19. Ureteral access sheath facilitates inspection of incision of ureteropelvic junction.
Auge BK; Wu NZ; Pietrow PK; Delvecchio FC; Preminger GM
J Urol; 2003 Mar; 169(3):1070-3. PubMed ID: 12576848
[TBL] [Abstract][Full Text] [Related]
20. Occult ureteropelvic junction obstruction presenting as anuria and urinary ascites in an infant with antenatal, unilateral hydronephrosis.
Hirselj DA; Zmaj PM; Firlit CF
J Pediatr Urol; 2009 Oct; 5(5):405-7. PubMed ID: 19427816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
